FTC Investigates Zicam “3X Faster” Cold Resolution Claims
This article was originally published in The Tan Sheet
Executive Summary
FTC is investigating whether Matrixx Initiatives engaged in deceptive or unfair advertising practices for the firm's Zicam cold remedy line, according to the company